| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

From the Departments of Pathology*and Neurology,
University of Washington, Seattle, Washington
Niemann-Pick type C disease (NPC) is characterized by neurodegeneration secondary to impaired cholesterol trafficking and excessive glycosphingolipid storage. Abnormal cholesterol and ganglioside metabolism may influence the generation and aggregation of amyloidogenic fragments (ie, C99 and Aß) from amyloid-ß precursor protein (APP), crucial factors causing neurodegeneration in Alzheimers disease. To reveal whether abnormal accumulation and aggregation of APP fragments also occurs in NPC, we studied their expression in cultured cortical neurons treated with U18666A, a compound widely used to induce NPC defects, and also in brain tissues from NPC patients. U18666A treatment resulted in increased intraneuronal levels of C99 and insoluble Aß42, which were distributed among early and late endosomes, in compartments distinct from where endogenous cholesterol accumulates. Analyses of NPC brains revealed that C99 or other APP C-terminal fragments (APP-CTF), but not Aß42, accumulated in Purkinje cells, mainly in early endosomes. In contrast, in hippocampal pyramidal neurons, the major accumulated species was Aß42, in late endosomes. Similar to what has been shown in Alzheimers disease, cathepsin D, a lysosomal hydrolase, was redistributed to early endosomes in NPC Purkinje cells, where it co-localized with C99/APP-CTF. Our results suggest that endosomal abnormalities related to abnormal lipid trafficking in NPC may contribute to abnormal APP processing and Aß42/C99/APP-CTF deposition.
This article has been cited by other articles:
![]() |
Y. Jiang, K. A. Mullaney, C. M. Peterhoff, S. Che, S. D. Schmidt, A. Boyer-Boiteau, S. D. Ginsberg, A. M. Cataldo, P. M. Mathews, and R. A. Nixon Alzheimer's-related endosome dysfunction in Down syndrome is A{beta}-independent but requires APP and is reversed by BACE-1 inhibition PNAS, January 26, 2010; 107(4): 1630 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Amritraj, K. Peake, A. Kodam, C. Salio, A. Merighi, J. E. Vance, and S. Kar Increased Activity and Altered Subcellular Distribution of Lysosomal Enzymes Determine Neuronal Vulnerability in Niemann-Pick Type C1-Deficient Mice Am. J. Pathol., December 1, 2009; 175(6): 2540 - 2556. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Cataldo, P. M. Mathews, A. B. Boiteau, L. C. Hassinger, C. M. Peterhoff, Y. Jiang, K. Mullaney, R. L. Neve, J. Gruenberg, and R. A. Nixon Down Syndrome Fibroblast Model of Alzheimer-Related Endosome Pathology: Accelerated Endocytosis Promotes Late Endocytic Defects Am. J. Pathol., August 1, 2008; 173(2): 370 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liao, Y. Yao, J. Liu, Z. Yu, S. Cheung, A. Xie, X. Liang, and X. Bi Cholesterol Accumulation Is Associated with Lysosomal Dysfunction and Autophagic Stress in Npc1 / Mouse Brain Am. J. Pathol., September 1, 2007; 171(3): 962 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. J. Park, J. L. Hallows, P. Chakrabarty, P. Davies, and I. Vincent Conditional Neuronal Simian Virus 40 T Antigen Expression Induces Alzheimer-Like Tau and Amyloid Pathology in Mice J. Neurosci., March 14, 2007; 27(11): 2969 - 2978. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Tate and P. M. Mathews Targeting the Role of the Endosome in the Pathophysiology of Alzheimer's Disease: A Strategy for Treatment Sci. Aging Knowl. Environ., June 28, 2006; 2006(10): re2 - re2. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Walterfang, M. Fietz, M. Fahey, D. Sullivan, P. Leane, D. I. Lubman, and D. Velakoulis The Neuropsychiatry of Niemann-Pick Type C Disease in Adulthood J Neuropsychiatry Clin Neurosci, May 1, 2006; 18(2): 158 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Almeida, R. H. Takahashi, and G. K. Gouras Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J. Neurosci., April 19, 2006; 26(16): 4277 - 4288. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Cole, A. Grudzien, I. O. Manhart, B. L. Kelly, H. Oakley, and R. Vassar Statins Cause Intracellular Accumulation of Amyloid Precursor Protein, {beta}-Secretase-cleaved Fragments, and Amyloid {beta}-Peptide via an Isoprenoid-dependent Mechanism J. Biol. Chem., May 13, 2005; 280(19): 18755 - 18770. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Langui, N. Girardot, K. H. El Hachimi, B. Allinquant, V. Blanchard, L. Pradier, and C. Duyckaerts Subcellular Topography of Neuronal A{beta} Peptide in APPxPS1 Transgenic Mice Am. J. Pathol., November 1, 2004; 165(5): 1465 - 1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Nixon Niemann-Pick Type C Disease and Alzheimer's Disease: The APP-Endosome Connection Fattens Up Am. J. Pathol., March 1, 2004; 164(3): 757 - 761. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |